Investigating two medicinal combinations of Ropivacaine-Dexmedetomidine and Ropivacaine-Ketamine by subcutaneous method in postoperative pain control in Inguinal hernia candidate patients
Phase 3
Recruiting
- Conditions
- Inguinal herniaInguinal hernia.
- Registration Number
- IRCT20191104045328N23
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Candidates for inguinal hernia surgery between the ages of 18 and 65
Body mass index below 30
Consent to participate in the study
Exclusion Criteria
History of allergy to studied drugs
Smoking
Underlying disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method